OQROGet OQRO Pro
Insider trade

Neuropace (NPCE)CHIEF MEDICAL OFFICER sold ~$48K

Martha Morrell, CHIEF MEDICAL OFFICER at Neuropace, sold ~$48K of Neuropace shares.

~$48K
Approx. value · 3,200 sh @ $15.01
87K
Holds after · shares reported
Traded
Jan 24, 2025
Filed
Jan 28, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 24, 2025 · this disclosureInsiderOfficer sold ~$48K of NPCE shares in the open market

What came next

  1. Jan 29, 2025InsiderOfficer sold ~$1.5K of NPCE shares in the open market
  2. Jan 30, 2025InsiderOfficer sold ~$3K of NPCE shares in the open market
  3. Feb 20, 2025Insider10% owner sold ~$49.5M of NPCE shares in the open market
  4. Feb 21, 2025InsiderOfficer sold ~$1.07M of NPCE shares in the open market
  5. May 14, 2025Insider · 1 personInsiders: 2 sales (~$2.7M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Neuropace

For Neuropace, OQRO holds 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NPCE page.

Other recent filings by Martha Morrell, CHIEF MEDICAL OFFICER

The full history of Martha Morrell, CHIEF MEDICAL OFFICER is on the profile page.

How this filing works

Other disclosures at Neuropace

Everything OQRO holds on this company is on its NPCE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data